AstraZeneca's Symbicort Inhaler Triggers Patent Suit
Texas-based Accuhale LLC hit AstraZeneca PLC with a patent infringement suit Thursday, claiming the pharmaceutical giant violated federal law with its Symbicort pressurized metered-dose inhaler for the management of asthma and...To view the full article, register now.
Already a subscriber? Click here to view full article